Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 182

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 182
---
fusion OpCo in accordance with the Delaware limited liability company act, whereupon the separate existence of Merger Sub II will cease, and Enfusion OpCo will continue as the surviving entity in the LLC Merger, (b) Merger Sub
will be merged with and into Enfusion in accordance with the DGCL, whereupon the separate existence of Merger Sub will cease, and Enfusion will continue as the surviving corporation in the Merger and (c) if the Second Effective Time occurs in
accordance with the terms and conditions of the Merger Agreement, the Surviving Corporation will be merged with and into Acquirer in accordance with the DGCL, whereupon the separate existence of the Surviving Corporation will cease, and Acquirer
will continue as the surviving corporation in the Second Merger. The effective time of each of the Transactions will occur upon the filing of the applicable certificate of merger with the Secretary of State of the State of Delaware (or at such later
time as the parties to each such Merger may agree and specify in such certificate of merger); provided that the Effective Time will occur immediately after LLC Merger Effective Time; provided further that the Second Effective Time,
assuming each of the conditions to the Second Merger will have been satisfied as of the Closing Date but prior to the Effective Time, will occur after the Effective Time.

115

Closing and Effective Time

The Merger Agreement provides that the Closing will take place at 8:00 a.m. Eastern Time on the second business day following the day on
which the last of the conditions to Closing (described in the section of this Proxy Statement/Prospectus titled “—Conditions to the Transactions”) has been satisfied or waived (to the extent waivable under the Merger Agreement) (other
than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver (to the extent waivable under the Merger Agreement) of those conditions), or such other time and date as may be mutually agreed
in writing by the parties to the Merger Agreement. Notwithstanding the foregoing, if the Marketing Period (defined below under “—Marketing Period”) has not ended at the time of the satisfaction or waiver (to the extent waivable under
the Merger Agreement) of the conditions to Closing, the Closing will instead occur on the date that is the earlier to occur of (i) any business day during the Marketing Period specified by Clearwater to Enfusion on no fewer than two business
days’